Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group studyGini F. Fleming, James V. Fiorica, J.T. Thigpen et al.|Gynecologic Oncology|2009Cited by 297
Advanced epithelial ovarian cancer: 1993 consensus statementsDarlene Allen, Elisabeth G.E. de Vries, J. Baak et al.|Annals of Oncology|1993Cited by 185